Pfizer sues Metsera, Novo Nordisk
Digest more
For Novo, it marks the boldest move yet for recently appointed CEO Maziar Mike Doustdar. In response to a slowdown in sales growth for its blockbuster obesity drug Wegovy, Doustdar has already ...
The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...
From a more company-specific point of view, Pfizer has also agreed to buy Metsera. This will help the company deal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results